IXICO hosts Alzheimer's Disease Expert Symposium
IXICO, the digital technologies company serving neuroscience, is today holding an Expert Symposium on the impact and future of imaging and digital biomarkers in Alzheimer’s disease. The symposium is set to coincide with the Alzheimer’s Association International Conference (AAIC) in London, UK.
Speakers include Frederik Barkhof, AMYPAD Project Coordinator and Professor of Neuroradiology at VUmc and UCL and Derek Hill, President of Regulatory Science and External Relations at IXICO.
A key highlight will be a discussion on the Amyloid Imaging to Prevent Alzheimer’ Disease (AMYPAD) programme, which is a collaboration between leading academic, healthcare and pharmaceutical partners. AMYPAD’s two key objectives are to advance the use of amyloid brain scans to improve the diagnosis of Alzheimer’s disease and to better select the right patients, earlier in the disease course, for clinical trials targeting the prevention of Alzheimer’s disease.
IXICO’s team will also present automated data analysis methods for enriching and phenotyping patients, the standardisation of quantitative amyloid imaging biomarkers together with the validation and regulatory path for biosensor based digital biomarkers and their application in Alzheimer’s disease clinical trials. The symposium takes place at Tower Bridge and recordings of the evening’s speakers and discussion will be available as a webinar following the event.